Connect with us

Health

Adding glass of milk in breakfast can lower blood glucose

Raghu Kshitiz

Published

on

Several research studies have attempted to find a link between drinking milk and a reduced risk for experiencing type 2 diabetes and a new research has found that adding a glass of milk in breakfast is the perfect energy boost for body needs to get through the day.

According to a study published in the Journal of Dairy Science, consuming milk with breakfast cereal reduced postprandial blood glucose concentration compared with water, and high dairy protein concentration reduced postprandial blood glucose concentration compared with normal dairy protein concentration.

H Douglas Goff, PhD, and the team of scientists from the Human Nutraceutical Research Unit at the University of Guelph, in collaboration with the University of Toronto, examined the effects of consuming high-protein milk for breakfast on blood glucose levels.

The high-protein treatment also reduced appetite after the second meal compared with the low-protein equivalent.

“Metabolic diseases are on the rise globally, with type 2 diabetes and obesity as leading concerns in human health. Thus, there is an impetus to develop dietary strategies for the risk reduction and management of obesity and diabetes to empower consumers to improve their personal health,” Goff and his team noted.

ALSO READ :  Our energy focuses on economic development : Maoist Chair Dahal

Although the team only found a modest difference in food consumption at the lunch meal when increasing whey protein at breakfast, they did find that milk consumed with a high-carbohydrate breakfast reduced blood glucose even after lunch, and high-protein milk had a greater effect.

Milk with an increased proportion of whey protein had a modest effect on pre-lunch blood glucose, achieving a greater decrease than that provided by regular milk.

Likewise, a 2014 study from Lund University in Sweden published in the American Journal of Clinical Nutrition found eating high-fat milk and yogurt reduces a person’s type 2 diabetes risk by as much as one-fifth.

Another study published in the 2011 American Journal of Clinical Nutrition tracked the relationship between a person’s dairy consumption during adolescence and their risk for type 2 diabetes as an adult. The researchers concluded that “higher dairy product intake during adolescence is associated with a lower risk of type 2 diabetes.”

Continue Reading

Health

Diabetes drug might ease heart failure risk

Gorkha Post

Published

on

A new research has showed that the diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure.

According to the findings were published in the New England Journal of Medicine to coincide with their presentation at the annual meeting of the American Heart Association in Chicago, Type 2 diabetics who took Farxiga saw their odds of hospitalization for heart failure drop by 27 percent compared to those who took a placebo.

Farxiga is a type of drug called a SGLT2 inhibitor. The compound is called dapagliflozin.

The study included more than 17,000 type 2 diabetes patients aged 40 and older. Nearly 7,000 had heart disease and more than 10,000 had numerous risk factors for heart disease, Wiviott’s group said.

Patients were randomly assigned to take a dummy placebo pill or 10 milligrams of Farxiga each day.

ALSO READ :  Three of a single family killed as landslide buries house in Salyan

“When it comes to helping our patients control and manage blood glucose, the ‘how’ appears to be as important [as] the ‘how much,” said study author Dr Stephen Wiviott, a cardiovascular medicine specialist at Brigham and Women’s Hospital in Boston.

“When choosing a therapy, trial results like these can help us make an informed decision about what treatments are not only safe and effective for lowering blood glucose but can also reduce risk of heart and kidney complications,” Wiviott said in a hospital news release.

Taking the drug did not reduce the risk of heart attack, stroke and cardiovascular-related death, the research team noted. However, patients who took the drug did see healthy declines in their blood sugar levels, plus an added bonus: a 27 percent decrease in their risk of hospitalization for heart failure.

Their risk of kidney failure and death from kidney failure also fell, researchers noted.

Two other recent studies of this class of drugs show that they “robustly and consistently improve heart and kidney outcomes in a broad population of patients with diabetes,” Wiviott noted.

With Inputs from HealthDay

Continue Reading

TOP PICKS